Cargando…

Guidance for the prevention and treatment of the post-thrombotic syndrome

The post-thrombotic syndrome (PTS) is a frequent, potentially disabling complication of deep vein thrombosis (DVT) that reduces quality of life and is costly. Clinical manifestations include symptoms and signs such as leg pain and heaviness, edema, redness, telangiectasia, new varicose veins, hyperp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahn, Susan R., Galanaud, Jean-Philippe, Vedantham, Suresh, Ginsberg, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715836/
https://www.ncbi.nlm.nih.gov/pubmed/26780743
http://dx.doi.org/10.1007/s11239-015-1312-5
_version_ 1782410486084534272
author Kahn, Susan R.
Galanaud, Jean-Philippe
Vedantham, Suresh
Ginsberg, Jeffrey S.
author_facet Kahn, Susan R.
Galanaud, Jean-Philippe
Vedantham, Suresh
Ginsberg, Jeffrey S.
author_sort Kahn, Susan R.
collection PubMed
description The post-thrombotic syndrome (PTS) is a frequent, potentially disabling complication of deep vein thrombosis (DVT) that reduces quality of life and is costly. Clinical manifestations include symptoms and signs such as leg pain and heaviness, edema, redness, telangiectasia, new varicose veins, hyperpigmentation, skin thickening and in severe cases, leg ulcers. The best way to prevent PTS is to prevent DVT with pharmacologic or mechanical thromboprophylaxis used in high risk patients and settings. In patients whose DVT is treated with a vitamin K antagonist, subtherapeutic INRs should be avoided. We do not suggest routine use of elastic compression stockings (ECS) after DVT to prevent PTS, but in patients with acute DVT-related leg swelling that is bothersome, a trial of ECS is reasonable. We suggest that selecting patients for catheter-directed thrombolytic techniques be done on a case-by-case basis, with a focus on patients with extensive thrombosis, recent symptoms onset, and low bleeding risk, who are seen at experienced hospital centers. For patients with established PTS, we suggest prescribing 20–30 mm Hg knee-length ECS to be worn daily. If ineffective, a stronger pressure stocking can be tried. We suggest that intermittent compression devices or pneumatic compression sleeve units be tried in patients with moderate-to-severe PTS whose symptoms are inadequately controlled with ECS alone. We suggest that a supervised exercise training program for 6 months or more is reasonable for PTS patients who can tolerate it. We suggest that management of post-thrombotic ulcers should involve a multidisciplinary approach. We briefly discuss upper extremity PTS and PTS in children.
format Online
Article
Text
id pubmed-4715836
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-47158362016-01-22 Guidance for the prevention and treatment of the post-thrombotic syndrome Kahn, Susan R. Galanaud, Jean-Philippe Vedantham, Suresh Ginsberg, Jeffrey S. J Thromb Thrombolysis Article The post-thrombotic syndrome (PTS) is a frequent, potentially disabling complication of deep vein thrombosis (DVT) that reduces quality of life and is costly. Clinical manifestations include symptoms and signs such as leg pain and heaviness, edema, redness, telangiectasia, new varicose veins, hyperpigmentation, skin thickening and in severe cases, leg ulcers. The best way to prevent PTS is to prevent DVT with pharmacologic or mechanical thromboprophylaxis used in high risk patients and settings. In patients whose DVT is treated with a vitamin K antagonist, subtherapeutic INRs should be avoided. We do not suggest routine use of elastic compression stockings (ECS) after DVT to prevent PTS, but in patients with acute DVT-related leg swelling that is bothersome, a trial of ECS is reasonable. We suggest that selecting patients for catheter-directed thrombolytic techniques be done on a case-by-case basis, with a focus on patients with extensive thrombosis, recent symptoms onset, and low bleeding risk, who are seen at experienced hospital centers. For patients with established PTS, we suggest prescribing 20–30 mm Hg knee-length ECS to be worn daily. If ineffective, a stronger pressure stocking can be tried. We suggest that intermittent compression devices or pneumatic compression sleeve units be tried in patients with moderate-to-severe PTS whose symptoms are inadequately controlled with ECS alone. We suggest that a supervised exercise training program for 6 months or more is reasonable for PTS patients who can tolerate it. We suggest that management of post-thrombotic ulcers should involve a multidisciplinary approach. We briefly discuss upper extremity PTS and PTS in children. Springer US 2016-01-16 2016 /pmc/articles/PMC4715836/ /pubmed/26780743 http://dx.doi.org/10.1007/s11239-015-1312-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Kahn, Susan R.
Galanaud, Jean-Philippe
Vedantham, Suresh
Ginsberg, Jeffrey S.
Guidance for the prevention and treatment of the post-thrombotic syndrome
title Guidance for the prevention and treatment of the post-thrombotic syndrome
title_full Guidance for the prevention and treatment of the post-thrombotic syndrome
title_fullStr Guidance for the prevention and treatment of the post-thrombotic syndrome
title_full_unstemmed Guidance for the prevention and treatment of the post-thrombotic syndrome
title_short Guidance for the prevention and treatment of the post-thrombotic syndrome
title_sort guidance for the prevention and treatment of the post-thrombotic syndrome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715836/
https://www.ncbi.nlm.nih.gov/pubmed/26780743
http://dx.doi.org/10.1007/s11239-015-1312-5
work_keys_str_mv AT kahnsusanr guidanceforthepreventionandtreatmentofthepostthromboticsyndrome
AT galanaudjeanphilippe guidanceforthepreventionandtreatmentofthepostthromboticsyndrome
AT vedanthamsuresh guidanceforthepreventionandtreatmentofthepostthromboticsyndrome
AT ginsbergjeffreys guidanceforthepreventionandtreatmentofthepostthromboticsyndrome